This study is looking at a new way to help older adults (75 and older) with type 2 diabetes who take insulin and are at high risk for low blood sugar (hypoglycemia). It compares two groups: one receives three educational group sessions and a continuous glucose monitor (CGM), and the other receives their usual care. The goal is to see if the educational program with CGMs can reduce episodes of low blood sugar. To join, you must be 75 or older, have type 2 diabetes, use insulin, have a history of low blood sugar, speak English, and use email/internet. The study aims to enroll 360 people. The current recruitment status is unclear.

Study design

This is a randomized clinical trial with 360 participants. It compares an educational program with continuous glucose monitoring to usual care.

What's involved

Participants in the SAGE Group will attend 3 educational group sessions and receive CGMs. The duration of participation is not specified, but primary outcomes are measured at 6 and 12 months.

Compensation

Not stated in the trial record.

Follow-up

The study will measure outcomes at 6 and 12 months after the start date.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.